Agilent to Acquire North American CDMO BIOVECTRA

Expands Agilent's end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturingSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today

BusinesswireJul 22 09:01 ET

Institutional Investors Must Be Pleased After a 8.9% Gain Last Week That Adds to CRISPR Therapeutics AG's (NASDAQ:CRSP) One-year Returns

Yahoo FinanceJul 18 07:47 ET

CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?

Zacks Jul 17 06:10 ET

CRISPR Therapeutics (NASDAQ:CRSP) Adds US$359m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 54%

Investing in stocks inevitably means buying into some companies that perform poorly. But long term CRISPR Therapeutics AG (NASDAQ:CRSP) shareholders have had a particularly rough ride in the last

Simply Wall StJul 16 15:52 ET

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Yahoo FinanceJul 16 04:15 ET

Ark's Cathie Wood Blasts Big Tech. She Prefers Palantir and These Other Stocks.

Cathie Wood's flagship ARK Innovation exchange-traded fund is 72% below its peak while the S&P 500 is hitting all-time highs.

BarronsJul 11 09:04 ET